1. D’Onofrio, F., Pempinello, R., Romis, L.: Clinical and metabolic observations with a new synthetic oral antidiabetic agent, Glipizide. Arzneimittelforschung 2(11), 1879–1881 (1972).
2. Brogden, R.N., Heel, R.C., Pakes, G.E., Speight, T.M., Avery, G.S.: Glipizide: a review of its pharmacological properties and therapeutic use. Drugs 18, 329–353 (1979).
3. Jamzad, S., Fassihi, R.: Role of surfactant and pH on dissolution properties of fenofibrate and glipizide—a technical note. AAPS PharmSciTech. 7, E1–E6 (2006).
4. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER). Chemistry review for metaglip tablets. Available at http://www.fda.gov/cder/foi/nda/2002/21–460_metaglip_Chemr.pdf . Accessed:March 29, 2007.
5. Gidwani, S.K., Singnurkar, P., Tiwari, P.K.: Glipizide-cyclodextrin inclusion compounds and their pharmaceutical compositions. US Patent 6,464,988 B1, 15 Oct 2002.